Found: 37
Select item for more details and to access through your institution.
Vascular normalization: a real benefit?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 275, doi. 10.1007/s00280-011-1683-z
- By:
- Publication type:
- Article
UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
UGT1A1*1/*28 and *1/ *6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 279, doi. 10.1007/s00280-010-1485-8
- By:
- Publication type:
- Article
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 285, doi. 10.1007/s00280-010-1479-6
- By:
- Publication type:
- Article
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 293, doi. 10.1007/s00280-010-1478-7
- By:
- Publication type:
- Article
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 301, doi. 10.1007/s00280-010-1487-6
- By:
- Publication type:
- Article
Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 309, doi. 10.1007/s00280-010-1480-0
- By:
- Publication type:
- Article
Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Clinical impact of K- ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 317, doi. 10.1007/s00280-010-1496-5
- By:
- Publication type:
- Article
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 325, doi. 10.1007/s00280-010-1486-7
- By:
- Publication type:
- Article
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 337, doi. 10.1007/s00280-010-1494-7
- By:
- Publication type:
- Article
Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 343, doi. 10.1007/s00280-010-1489-4
- By:
- Publication type:
- Article
Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Anticancer effect of ( E)-2-hydroxy-3′,4,5′-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 349, doi. 10.1007/s00280-010-1464-0
- By:
- Publication type:
- Article
Conjugation of chlorin p to histamine enhances its cellular uptake and phototoxicity in oral cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 359, doi. 10.1007/s00280-010-1492-9
- By:
- Publication type:
- Article
Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 371, doi. 10.1007/s00280-010-1493-8
- By:
- Publication type:
- Article
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 379, doi. 10.1007/s00280-010-1481-z
- By:
- Publication type:
- Article
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 389, doi. 10.1007/s00280-010-1495-6
- By:
- Publication type:
- Article
Lack of in vivo cross-resistance with 4'-thio-ara-C against drug-resistant murine P388 and L1210 leukemias.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Lack of in vivo cross-resistance with 4′-thio-ara-C against drug-resistant murine P388 and L1210 leukemias.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 399, doi. 10.1007/s00280-010-1498-3
- By:
- Publication type:
- Article
Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 405, doi. 10.1007/s00280-010-1500-0
- By:
- Publication type:
- Article
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 415, doi. 10.1007/s00280-010-1508-5
- By:
- Publication type:
- Article
Clinical benefit of early phase clinical trial participation for advanced sarcoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 423, doi. 10.1007/s00280-010-1484-9
- By:
- Publication type:
- Article
The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 431, doi. 10.1007/s00280-010-1499-2
- By:
- Publication type:
- Article
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 445, doi. 10.1007/s00280-010-1505-8
- By:
- Publication type:
- Article
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 457, doi. 10.1007/s00280-010-1510-y
- By:
- Publication type:
- Article
Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 465, doi. 10.1007/s00280-010-1502-y
- By:
- Publication type:
- Article
Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 477, doi. 10.1007/s00280-010-1504-9
- By:
- Publication type:
- Article
Antitumor effects of ( S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 489, doi. 10.1007/s00280-010-1501-z
- By:
- Publication type:
- Article
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 497, doi. 10.1007/s00280-010-1503-x
- By:
- Publication type:
- Article
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 505, doi. 10.1007/s00280-010-1506-7
- By:
- Publication type:
- Article
Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 513, doi. 10.1007/s00280-010-1518-3
- By:
- Publication type:
- Article
Determination of 5-fluorouracil and dihydrofluorouracil levels by using a liquid chromatography-tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 525, doi. 10.1007/s00280-010-1528-1
- By:
- Publication type:
- Article
Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 531, doi. 10.1007/s00280-010-1522-7
- By:
- Publication type:
- Article
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- Report
Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 547, doi. 10.1007/s00280-011-1620-1
- By:
- Publication type:
- Article